• The technology described in this briefing is Coban 2 compression bandage for venous leg ulcers.

  • The innovative aspect is that it is thinner than 4‑layer bandages. This aims to improve mobility and convenience.

  • The intended place in therapy would be as an alternative to current compression bandages in selected people with venous leg ulcers.

  • The main points from the evidence summarised in this briefing are from 3 studies (2 in UK, 1 in Italy; comprising 2 randomised controlled trials [RCTs] and 1 observational study) including a total of 1,456 adults with venous leg ulcers. The evidence is limited in quantity and quality. One randomised study showed that Coban 2 slipped significantly less than 4‑layer bandages. The studies showed Coban 2 is as effective for wound healing as other compression bandages.

  • Key uncertainties around the evidence or technology are that there are no studies showing better wound healing than 4‑layer bandages.

  • The cost of Coban 2 is £8.24 per unit (excluding VAT). The resource impact would likely be similar to standard care (£4 to £15 depending on size of bandage).